SG11201405028UA - Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia - Google Patents

Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia

Info

Publication number
SG11201405028UA
SG11201405028UA SG11201405028UA SG11201405028UA SG11201405028UA SG 11201405028U A SG11201405028U A SG 11201405028UA SG 11201405028U A SG11201405028U A SG 11201405028UA SG 11201405028U A SG11201405028U A SG 11201405028UA SG 11201405028U A SG11201405028U A SG 11201405028UA
Authority
SG
Singapore
Prior art keywords
myopia
disease
prevention
treatment
slowing
Prior art date
Application number
SG11201405028UA
Inventor
Atanu Ghosh
Michael John Collins
Scott Andrew Read
Brett Ashley Davis
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Publication of SG11201405028UA publication Critical patent/SG11201405028UA/en

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/14—Mirrors; Prisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024—Methods of designing ophthalmic lenses
    • G02C7/027—Methods of designing ophthalmic lenses considering wearer's parameters
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/06—Lenses; Lens systems ; Methods of designing lenses bifocal; multifocal ; progressive
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/06—Lenses; Lens systems ; Methods of designing lenses bifocal; multifocal ; progressive
    • G02C7/061—Spectacle lenses with progressively varying focal power
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/1005—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring distances inside the eye, e.g. thickness of the cornea
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/24—Myopia progression prevention
SG11201405028UA 2012-02-21 2013-02-21 Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia SG11201405028UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261601202P 2012-02-21 2012-02-21
PCT/AU2013/000160 WO2013123558A1 (en) 2012-02-21 2013-02-21 Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia

Publications (1)

Publication Number Publication Date
SG11201405028UA true SG11201405028UA (en) 2014-09-26

Family

ID=49004856

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405028UA SG11201405028UA (en) 2012-02-21 2013-02-21 Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia

Country Status (10)

Country Link
US (1) US20150036102A1 (en)
EP (1) EP2817673A4 (en)
JP (1) JP2015513415A (en)
KR (1) KR20140138756A (en)
CN (1) CN104246581A (en)
AU (1) AU2013202323A1 (en)
IN (1) IN2014MN01812A (en)
PH (1) PH12014501874A1 (en)
SG (1) SG11201405028UA (en)
WO (1) WO2013123558A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI588560B (en) 2012-04-05 2017-06-21 布萊恩荷登視覺協會 Lenses, devices, methods and systems for refractive error
US9201250B2 (en) 2012-10-17 2015-12-01 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
TWI600418B (en) 2012-10-17 2017-10-01 布萊恩荷登視覺協會 Lenses, devices, methods and systems for refractive error
JP6495006B2 (en) * 2014-12-26 2019-04-03 ホヤ レンズ タイランド リミテッドＨＯＹＡ Ｌｅｎｓ Ｔｈａｉｌａｎｄ Ｌｔｄ A pair of eyeglass lenses for both eyes, a manufacturing method thereof, a supply system, and a supply program
CN107111158A (en) 2014-12-26 2017-08-29 豪雅镜片泰国有限公司 Eyeglass, its manufacture method, feed system and supply program
JP6495005B2 (en) * 2014-12-26 2019-04-03 ホヤ レンズ タイランド リミテッドＨＯＹＡ Ｌｅｎｓ Ｔｈａｉｌａｎｄ Ｌｔｄ A pair of eyeglass lenses for both eyes, a manufacturing method thereof, a supply system, and a supply program
CN105467617A (en) * 2016-02-16 2016-04-06 侯绪华 Defocused progressive multi-focus contact lens
CN115185103A (en) 2016-08-01 2022-10-14 华盛顿大学 Ophthalmic lens for the treatment of myopia
US10048512B2 (en) * 2016-10-08 2018-08-14 eyeBrain, Medical, Inc. Low-convergence spectacles
US20180196281A1 (en) 2017-01-06 2018-07-12 eyeBrain Medical, Inc. Prismatic contact lens
DE102017000777A1 (en) * 2017-01-27 2018-08-02 Rodenstock Gmbh Method for considering different prismatic corrections in the distance and near
US11718052B2 (en) 2017-05-08 2023-08-08 Sightglass Vision, Inc. Contact lenses for reducing myopia and methods for making the same
US10884264B2 (en) 2018-01-30 2021-01-05 Sightglass Vision, Inc. Ophthalmic lenses with light scattering for treating myopia
CN110515219A (en) * 2019-07-19 2019-11-29 浙江工业大学 A kind of production method of anti-fatigue glasses
WO2023209540A1 (en) * 2022-04-25 2023-11-02 Novasight Ltd. Method and system for assessing axial length of the eye

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6505934B1 (en) * 2001-04-27 2003-01-14 Johnson & Johnson Vision Care, Inc. Progressive addition lenses with prism power added to improve wearer comfort
DE60304631T2 (en) * 2002-07-22 2006-11-09 Lin, Chao-Chyun Prism-based device and method for dynamically training human eyesight
FR2850763B1 (en) * 2003-02-03 2005-07-01 Essilor Int APHTHALMIC LENS WITH PROGRESSIVE ADDITION OF POWER AND PRISM
BRPI0617356B1 (en) * 2005-10-12 2018-02-14 Carl Zeiss Vision Australia Holdings Limited “Ophthalmic Lens Element, Method and System for Dispensing or Designing an Ophthalmic Lens Element to Correct Myopia in an Eye of the User”

Also Published As

Publication number Publication date
KR20140138756A (en) 2014-12-04
AU2013202323A1 (en) 2013-09-05
EP2817673A1 (en) 2014-12-31
US20150036102A1 (en) 2015-02-05
JP2015513415A (en) 2015-05-14
PH12014501874A1 (en) 2014-11-17
EP2817673A4 (en) 2016-03-02
CN104246581A (en) 2014-12-24
IN2014MN01812A (en) 2015-07-03
WO2013123558A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
SG11201405028UA (en) Slowing myopia progression and/or the treatment or prevention of myopia or a disease or condition associated with myopia
IL265774B (en) Diagnosis, prevention and treatment of diseases of the joint
PL3157512T3 (en) Use of cannabidiol in the treatment of epilepsy
HK1198631A1 (en) Prevention and treatment of ocular conditions
EP2890440A4 (en) Devices and methods for the treatment of vascular disease
HK1205128A1 (en) 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease 7--
HK1218071A1 (en) Inhibition of sema3a in the prevention and treatment of ocular hyperpermeability sema3a
IL253441A0 (en) Drug for preventing and/or treating polycystic kidney disease
LT2854910T (en) Ceramide levels in the treatment and prevention of infections
HK1212688A1 (en) Pyridone derivatives and their use in the treatment, amelioration or prevention of a viral disease
HK1211960A1 (en) Treating vascular disease and complications thereof
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
IL246286A0 (en) Pharmaceutical preparation for preventing and treating progressive myopia
IL242355B (en) Cannabidiol for the prevention and treatment of graft-versus-host disease
HK1211288A1 (en) Naphthyridinone derivatives and their use in the treatment,amelioration or prevention of a viral disease
PL2812009T3 (en) Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease
HK1186104A1 (en) Use of arctigenin in the manufacture of a medicament for treating or preventing brain glioma
AP2015008726A0 (en) Low-glycerin-formulations for hiv treatment and prevention
ZA201600894B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes
ZA201505093B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the treatment of atherosclerosis
GB201219696D0 (en) Agents for the prevention and/or treatment of central nervous system damamge